ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹23 Cr | ₹20 Cr | ₹26 Cr | ₹32 Cr | ₹34 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹23 Cr |
Mar2024 | ₹20 Cr |
Mar2023 | ₹26 Cr |
Mar2022 | ₹32 Cr |
Mar2021 | ₹34 Cr |
How is Deferred Tax Assets / Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹23 Cr | 16.96 | |
Mar2024 | ₹20 Cr | -22.57 | |
Mar2023 | ₹26 Cr | -18.68 | |
Mar2022 | ₹32 Cr | -6.33 | |
Mar2021 | ₹34 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ADVANCED ENZYME TECHNOLOGIES | ₹3,700.5 Cr | -2.1% | 1.7% | -15.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | -2.1% |
1.7% |
-15.4% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses